ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,220, issued on Sept. 15, was assigned to GRIFOLS WORLDWIDE OPERATIONS Ltd. (Dublin).

"Composition comprising albumin for use in the treatment of amyotrophic lateral sclerosis (ALS) by plasma exchange" was invented by Javier Jorba Ribes (Sant Cugat del Valles, Spain) and Antonio Manuel Paez Regadera (Sant Cugat del Valles, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition including albumin for use in the treatment of Amyotrophic Lateral Sclerosis (ALS), wherein the composition is administrated to the patient by plasma exchange using a volume of the composition equivalent to approximately 100% of the volume of plasma withdrawn from t...